By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Luminex today announced a deal with healthcare system Partners HealthCare for the discovery of biomarkers and development of clinical assays.

Partners HealthCare Center for Personalized Genetic Medicine will develop molecular diagnostic assays based on biomarkers discovered within the integrated health system to be run on Luminex's xMAP platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

The House of Lords in the UK approves a bill to allow mitochondrial donation.